B-D-Galactose

B-D-Galactose

SCHEMBL6676095

OC1CC=CO1.OCC1OC(O)C(O)C(O)C1O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LGALS3 P17931 3/20 0.39
LGALS1 P09382 2/20 0.39
LGALS9 O00182 1/20 0.39
LGALS8 O00214 1/20 0.39
CDA P32320 2/20 0.33
TYR P14679 1/20 0.33
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
SLC5A2 P31639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
B-D-Galactose SCHEMBL8527882 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL13220216 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL2441804 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL79549 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL18649521 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL23758905 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL9880688 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL10050866 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL21123450 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12
B-D-Galactose SCHEMBL17112445 0.77 LGALS3 (0.58) LGALS3LGALS1LGALS9LGALS8CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004037159-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING FAT METABOLISM OBETHERAPY BIOTECHNOLOGY (FR) 2004-05-06 WO disclosed